Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHRQ Obesity Report Recommends Behavior Therapy, Is Cautious On Drugs

Executive Summary

An Agency for Healthcare Research & Quality report recommends behavioral intervention to treat obesity but does not make a recommendation regarding drug therapy

You may also be interested in...



Medicare Obesity Policy Change Will Help Acomplia Launch, Sanofi Says

Medicare's recent announcement about obesity coverage policies sends a positive signal for the upcoming launch of Sanofi-Synthelabo's Acomplia, the company said during a July 21 conference call

Medicare Obesity Policy Change Will Help Acomplia Launch, Sanofi Says

Medicare's recent announcement about obesity coverage policies sends a positive signal for the upcoming launch of Sanofi-Synthelabo's Acomplia, the company said during a July 21 conference call

AHRQ Stepping Up Cost-Effectiveness Research; Says Key Is Openness

The Agency for Healthcare Research & Quality is ready to take on a new role in cost-effectiveness research, Director Carolyn Clancy, MD, said at an AHRQ National Advisory Council meeting Nov. 7

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel